Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Veterinary Sutures Market Size & Share 2026-2035
Report ID: GMI7168
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Veterinary Sutures Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Veterinary Sutures Market Size
The veterinary sutures market was valued at USD 245.0 million in 2025 and is projected to reach USD 259.5 million in 2026, expanding at a 6.0% CAGR from 2026 to 2035 to reach USD 438.0 million by 2035.
Veterinary Sutures Market Key Takeaways
Market Leader: Johnson & Johnson (Ethicon Vet) led with over 18.2% market share in 2025.
Leading Players: Top 5 players in this market include Johnson & Johnson (Ethicon Vet), B. Braun Melsungen, Medtronic, DemeTECH Corporation, CP Medical, which collectively held a market share of 49.7% in 2025.
The veterinary sutures market is evolving through a shift toward more predictable, synthetic wound-closure materials and a broader surgical case base in animal healthcare. Demand is shaped by the clinical requirements of companion animal surgery alongside livestock and equine care, while procedure authorization, material selection, and distributor access influence realized revenue across markets.
GMI Analyst View
Our analysis of historical demand-side data and distribution channel research confirms that the veterinary sutures market was valued at USD 208.0 million in 2022, establishing a pre-growth baseline from which compound expansion has since accelerated. The pace of growth from that base reflects a market already in structural transition, driven by surgical case volume gains in companion animal practice and the commercial displacement of legacy natural suture materials by synthetic alternatives.
Veterinary Sutures Market Trends, Growth Drivers & GMI Forecast Outlook
The market's outlook rests on a widening companion-animal surgical base and growing clinical preference for synthetic absorbable materials. These tailwinds are tempered by owner affordability constraints and uneven regulatory pathways, making procedure volumes and premium-material adoption the central variables shaping forecast realization.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
A larger companion-animal population expands the pool of animals that can progress from preventive care into surgical treatment over their lifetimes. Routine sterilization, soft-tissue repair, oncology procedures, and orthopedic interventions each create recurring wound-closure demand, while owners who increasingly regard animals as family members are more willing to consider procedures aimed at preserving mobility, comfort, and longevity.
European demand is reinforced by established referral networks, teaching hospitals, and clinically mature small-animal practices. The region's procedural base is especially relevant to suppliers because practices increasingly select materials according to tissue handling, needle configuration, absorption profile, and operating-room workflow rather than treating sutures as undifferentiated consumables.
Synthetic bioabsorbables are changing the revenue mix as clinicians prioritize predictable tensile retention and controlled absorption. Their role is most pronounced where internal closure, delicate tissue planes, and avoidance of post-operative suture removal matter clinically. This shift favors manufacturers able to offer reliable material performance across a broad range of gauges, needle types, and veterinary applications.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The affordability constraint is not limited to the price of the suture itself. Owners evaluate surgery as a bundled expense that includes diagnostics, anesthesia, operating time, hospitalization, and follow-up care. Where coverage is limited, practices can encounter delayed treatment decisions or preference for lower-cost clinical pathways, reducing procedure throughput and constraining conversion to premium closure materials.
Cost pressure also affects procurement decisions inside veterinary facilities. Clinics serving highly price-sensitive households may standardize on value-oriented materials, whereas hospitals with more complex case mixes can sustain a wider premium portfolio. The result is a market in which clinical preference does not always translate directly into purchasing behavior.
Fragmented approval, labeling, and sterility requirements add complexity for suppliers commercializing advanced suture formulations across multiple jurisdictions. Larger manufacturers can spread compliance investment across broader product portfolios and distribution networks, while smaller specialists may prioritize selected geographies, limiting the speed at which technical innovation reaches less established veterinary markets.
GMI Analyst View
We view demand growth as increasingly dependent on the quality of surgical case conversion rather than animal ownership alone. Companion-animal procedures support value creation when owners can authorize treatment and clinicians can select performance-led materials; where affordability intervenes, volume may persist but the pace of specification upgrading becomes more constrained.
Veterinary Sutures Market Segment Analysis
By Product Type
Absorbable Sutures
Absorbable sutures generated USD 142.1 million in 2025 and are projected to account for a 59.5% share of market revenue by 2035. Their expansion reflects the clinical appeal of controlled degradation in internal closure and soft-tissue procedures, where predictable handling and reduced removal requirements can improve workflow for both veterinary teams and animal owners.
Non-absorbable sutures held a 42.0% share of market revenue in 2025 and are projected to generate USD 177.4 million by 2035. The category retains a durable role in external closures and procedures requiring persistent tensile support, providing a clinically necessary counterweight to the increasing use of absorbable alternatives.
Polyglactin
Polyglactin sutures are projected to generate USD 115.6 million by 2035. Their relevance stems from broad usability in soft-tissue closure, where braided synthetic materials can provide familiar handling characteristics and a predictable absorption profile across companion-animal and specialist practice settings.
Nylon
Nylon sutures are projected to generate USD 74.5 million by 2035. The material remains important for skin and transcutaneous closures because its monofilament construction supports low tissue drag and practical removal after healing, particularly in routine clinic workflows.
By Animal Type
Small & Medium Animals
Small and medium animals generated USD 164.2 million in 2025 and are projected to hold a 69.5% share of market revenue by 2035. Companion-animal care supports a comparatively broad surgical mix, including routine procedures, specialist referrals, and interventions intended to preserve mobility or quality of life, creating demand for both standard and premium closure materials.
Large Animals
Large animals accounted for a 33.0% share of market revenue in 2025 and are expected to expand at a 5.2% CAGR from 2026 to 2035. Procurement in this segment is influenced by herd economics, farm-management priorities, equine sports medicine, and the need for materials that can withstand higher mechanical stress in large-animal tissue repair.
By Application
Soft Tissue Surgery
Soft tissue surgery generated USD 107.8 million in 2025 and is projected to account for a 43.6% share of market revenue by 2035. Its breadth across gastrointestinal, reproductive, oncological, and emergency procedures makes it the market's most consistent source of multi-layer closure demand and supports use of varied suture configurations within a single operation.
Orthopedic Surgery
Orthopedic surgery held a 24.0% share of market revenue in 2025 and is projected to generate USD 101.6 million by 2035. Increasing access to referral-based musculoskeletal care supports demand for high-strength closure materials, particularly where recovery protocols and tissue loading place greater emphasis on material integrity.
Dental Surgery
Dental surgery generated USD 34.3 million in 2025 and is expected to expand at a 6.7% CAGR from 2026 to 2035. Fine-gauge, rapidly absorbing sutures are particularly relevant in oral procedures, where tissue sensitivity and the difficulty of post-operative suture removal elevate the value of atraumatic closure.
Ophthalmic Surgery
Ophthalmic surgery accounted for a 9.0% share of market revenue in 2025 and is projected to generate USD 40.3 million by 2035. This specialty demands precise needles and fine material formats, creating a premium niche in which product reliability and surgeon familiarity can outweigh purely price-based purchasing decisions.
By End Use
Veterinary Clinics
Veterinary clinics held a 44.0% share of market revenue in 2025 and are projected to generate USD 188.1 million by 2035. Primary-care facilities purchase for a high volume of routine procedures, but their buying decisions remain closely connected to client affordability and distributor availability, favoring dependable products with clear value propositions.
Veterinary Hospitals
Veterinary hospitals generated USD 210.8 million by 2035 and held a 47.0% share of market revenue in 2025. Their complex inpatient and referral caseloads create disproportionate demand for specialized closure solutions, while clinician-led purchasing and integrated operating-room workflows improve the addressability of premium materials.
Research Centers
Research centers generated USD 22.1 million in 2025 and are expected to expand at a 5.9% CAGR from 2026 to 2035. Veterinary schools, comparative-medicine programs, and protocol-driven research facilities provide stable demand for well-characterized products, with standardization requirements favoring consistent material performance and supplier continuity.
GMI Analyst View
We see the segment mix shifting toward applications where closure material performance is part of the clinical proposition rather than a routine supply decision. Absorbable materials benefit most from this transition, but non-absorbables retain defensible demand where removal, permanent support, or external closure remains clinically appropriate.
Veterinary Sutures Market Regional Analysis
North America Veterinary Sutures Market Analysis
The veterinary sutures market in North America generated USD 90.7 million in 2025 and is projected to account for a 33.5% share of global revenue by 2035. The region's established referral infrastructure, high standards of companion-animal care, and broad distributor coverage support demand for clinically differentiated suture materials, even as affordability constraints affect elective procedure conversion.
United States
The United States generated USD 79.8 million in 2025 and is projected to reach USD 128.4 million by 2035. Its market is supported by extensive small-animal practice networks and specialist surgical capacity, although out-of-pocket treatment exposure remains an important constraint on elective procedure authorization.
Canada
Canada is projected to generate USD 18.3 million by 2035 and accounted for a 12.0% share of North American revenue in 2025. The country combines mature companion-animal care with growing use of specialist services, supporting demand for a broader range of surgical closure products.
Europe Veterinary Sutures Market Analysis
Europe is projected to generate USD 104.2 million by 2035 and held a 27.0% share of global revenue in 2025. The region's durable demand base is supported by established veterinary standards, deep specialist networks, and sustained procurement of performance-led products across companion-animal surgery.
Germany
Germany accounted for a 22.0% share of European revenue in 2025 and is projected to generate USD 22.3 million by 2035. Its dense network of veterinary practices, teaching hospitals, and established distributor relationships supports steady demand in a clinically mature market.
United Kingdom
The United Kingdom is projected to generate USD 21.4 million by 2035 and is expected to expand at a 5.0% CAGR from 2026 to 2035. Its combination of general-practice coverage, referral capacity, and comparatively supportive insurance dynamics sustains surgical care utilization.
France
France generated USD 11.3 million in 2025 and is projected to account for a 17.0% share of European revenue by 2035. Expanding companion-animal specialty care and urban referral networks are strengthening the market for procedure-specific closure materials.
Italy
Italy is projected to generate USD 12.6 million by 2035 and held a 12.0% share of European revenue in 2025. Urban veterinary capacity and rising owner expectations for oncology and orthopedic treatment support gradual expansion in surgical consumables demand.
Spain
Spain generated USD 6.6 million in 2025 and is expected to expand at a 5.1% CAGR from 2026 to 2035. Continued alignment with broader European clinical practices is encouraging wider use of synthetic absorbable materials in companion-animal surgery.
Asia Pacific Veterinary Sutures Market Analysis
The veterinary sutures market in Asia Pacific generated USD 58.8 million in 2025 and is expected to expand at an 8.6% CAGR from 2026 to 2035. Rapid growth in urban companion-animal ownership, expanding veterinary service capacity, and greater willingness to spend on advanced treatment make the region the principal source of incremental market momentum.
China
China generated USD 20.6 million in 2025 and is projected to account for a 41.5% share of Asia Pacific revenue by 2035. Veterinary infrastructure is broadening alongside urban pet ownership, creating demand across routine surgical care and higher-acuity procedures in major cities.
India
India is projected to generate USD 26.1 million by 2035 and is expected to expand at an 11.5% CAGR from 2026 to 2035. Organized hospital development and expanding access to specialty care are increasing the availability of surgical intervention beyond the largest metropolitan markets.
Japan
Japan held a 19.5% share of Asia Pacific revenue in 2025 and is projected to generate USD 18.7 million by 2035. Its mature companion-animal care market supports demand for premium products in specialties where clinical precision and material handling are particularly consequential.
Australia
Australia generated USD 7.9 million in 2025 and is projected to account for a 9.0% share of Asia Pacific revenue by 2035. Companion-animal surgery and a meaningful livestock care base together support demand across both fine-gauge and higher-strength suture categories.
South Korea
South Korea is projected to generate USD 10.0 million by 2035 and held an 8.5% share of Asia Pacific revenue in 2025. Urban demographic change and rising interest in companion-animal healthcare are supporting the expansion of specialty veterinary services.
Latin America Veterinary Sutures Market Analysis
Latin America is projected to generate USD 32.9 million by 2035 and held a 7.0% share of global revenue in 2025. Demand is shaped by expanding urban companion-animal care alongside livestock and equine surgical activity, with local distributor capability remaining important to manufacturer access.
Brazil
Brazil generated USD 9.4 million in 2025 and is projected to account for a 56.2% share of Latin American revenue by 2035. Its large companion-animal population and agricultural base create a diversified demand profile, while organized hospital groups are broadening access to higher-specification materials.
Mexico
Mexico is projected to generate USD 7.4 million by 2035 and held a 22.1% share of Latin American revenue in 2025. Formalization of urban companion-animal care operates alongside sustained demand from cattle and equine veterinary activity.
Argentina
Argentina generated USD 1.8 million in 2025 and is expected to expand at a 5.6% CAGR from 2026 to 2035. Equine practice linked to polo and thoroughbred racing provides a specialized source of demand for quality-sensitive surgical materials.
Middle East and Africa Veterinary Sutures Market Analysis
The Middle East and Africa generated USD 12.1 million in 2025 and is projected to reach USD 20.6 million by 2035. Growth is supported by developing urban companion-animal care in Gulf markets and livestock health activity across African markets, although infrastructure and regulatory variation continue to influence the pace of adoption.
South Africa
South Africa held a 22.3% share of regional revenue in 2025 and is projected to generate USD 4.1 million by 2035. Its comparatively developed veterinary sector and equine practice base support demand for surgical closure materials across companion and large-animal applications.
Saudi Arabia
Saudi Arabia is projected to generate USD 4.4 million by 2035 and is expected to expand at a 7.7% CAGR from 2026 to 2035. Companion-animal adoption in urban areas and government-supported livestock health programs create distinct demand channels for suppliers.
UAE
The UAE generated USD 1.9 million in 2025 and is projected to account for a 17.5% share of regional revenue by 2035. Premium companion-animal care in Dubai and Abu Dhabi supports demand for imported, clinically differentiated suture products.
GMI Analyst View
We interpret regional growth as a rebalancing of demand rather than a displacement of mature markets. North America and Europe remain critical for high-value clinical adoption, while Asia Pacific contributes the strongest expansion potential as veterinary capacity, urban pet ownership, and specialist treatment availability advance together.
Veterinary Sutures Market Share & Competitive Landscape
The veterinary sutures market share structure is moderately concentrated, with the five leading companies collectively holding a 49.7% share of global revenue in 2025. Large medical-device groups benefit from established clinical brands, manufacturing scale, and distributor relationships, while veterinary-focused specialists compete through product breadth, private-label supply, price positioning, and targeted channel access.
Johnson & Johnson (Ethicon Vet)
Johnson & Johnson, through Ethicon Vet, held an 18.2% market share in 2025. Its position is reinforced by a broad portfolio of established suture technologies and strong recognition among veterinary surgeons familiar with human-surgery material platforms, supporting premium positioning in specialist and hospital procurement.
B. Braun Melsungen
B. Braun Melsungen held an 11.8% market share in 2025. The company's integrated surgical offering strengthens its position where hospitals prefer consolidated purchasing across closure materials, accessories, and wound-management products, particularly across established European channels.
Medtronic
Medtronic held an 8.2% market share in 2025. Its presence in veterinary applications is supported by relationships with teaching hospitals and advanced surgical settings, where familiarity with broader procedural technology can support adoption of its closure portfolio.
DemeTECH Corporation
DemeTECH competes through a broad absorbable and non-absorbable portfolio, manufacturing consistency, and a comprehensive choice of gauges and needle configurations. Its ability to serve both branded and private-label channels broadens its reach across veterinary distributors and cost-conscious practice settings.
CP Medical
CP Medical has a focused position in veterinary sutures through established distributor relationships and private-label manufacturing. Its model demonstrates the importance of channel control in reaching independent veterinary practices, where purchasing often flows through established animal-health distribution networks.
Cencora
Cencora contributes supply-chain and procurement capability to the veterinary channel. Its role illustrates how distribution infrastructure can shape brand availability, inventory continuity, and purchasing efficiency for clinics and hospital groups.
AIP Medical, Dolphin Sutures, KATSAN, Lotus Surgicals, Neogen Corporation, Orion Sutures, SMI, Vetersut, and Vitrex Medical
Regional and specialist manufacturers compete by balancing price, material quality, product breadth, and localized distributor access. These suppliers are particularly relevant in markets where procurement sensitivity is high or where large multinational portfolios do not fully address local specifications and commercial requirements.
Recent Industry Developments
In July 2024, CP Medical was acquired by Riverpoint Medical, expanding the company's position within a broader surgical supply platform. The transaction highlights continued strategic interest in veterinary consumable manufacturing and in established distribution relationships that can support animal-health market access [5]Capstone Partners. "Capstone Partners Advised CP Medical on its Sale to Riverpoint Medical, a Portfolio Company of Arlington Capital Partners." capstonepartners.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →